HomeCompareMAIN vs ABBV

MAIN vs ABBV: Dividend Comparison 2026

MAIN yields 8.41% · ABBV yields 3.67% · See full DRIP projection below

vsEnter any two US tickers
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $17.3K in total portfolio value
10 years
MAIN
Main Street Capital Corporation
8.41%
Share price
$52.80
Annual div
$4.44
5Y div CAGR
5.1%
Payout ratio
82%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.2K
Annual income
$2,355.47
Full MAIN calculator →
ABBV
AbbVie Inc.
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — MAIN vs ABBV

Annual dividend income

MetricMAINABBV
Forward yield8.41%3.67%
Annual dividend / share$4.44$6.20
Payout ratio82%58%
1-year div growth3.7%4.7%
5-year div CAGR5.1%8.9%
Portfolio after 10y$57.2K$39.9K
Annual income after 10y$2,355.47$1,154.43
Total dividends collected$15.5K$7.2K
Payment frequencymonthlyquarterly
SectorBDCHealthcare

Year-by-year: MAIN vs ABBV ($10,000, DRIP)

YearMAIN PortfolioMAIN Income/yrABBV PortfolioABBV Income/yrGap
1$12,124$883.80$11,520$399.75+$604.00MAIN
2$14,629$1,001.91$13,261$450.98+$1.4KMAIN
3$17,573$1,130.42$15,255$508.41+$2.3KMAIN
4$21,022$1,269.75$17,536$572.74+$3.5KMAIN
5$25,049$1,420.29$20,145$644.78+$4.9KMAIN
6$29,738$1,582.45$23,126$725.38+$6.6KMAIN
7$35,182$1,756.64$26,532$815.52+$8.7KMAIN
8$41,488$1,943.25$30,420$916.26+$11.1KMAIN
9$48,775$2,142.72$34,855$1,028.80+$13.9KMAIN
10$57,179$2,355.47$39,914$1,154.43+$17.3KMAIN

MAIN vs ABBV: Complete Analysis 2026

MAINBDC

Main Street Capital is a Business Development Company providing debt and equity capital to lower middle market companies. It pays regular monthly dividends plus semi-annual special dividends. One of the few BDCs consistently trading at a premium to NAV, with an exceptional track record since its 2007 IPO. Often called the gold standard of BDCs.

Full MAIN Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

Frequently Asked Questions

Is MAIN or ABBV better for dividend income in 2026?
MAIN currently offers a 8.41% yield (4.44/share/year) while ABBV offers 3.67% (6.20/share/year). MAIN provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MAIN vs ABBV earn per year?
With $10,000 invested today: MAIN pays approximately $841/year. ABBV pays approximately $367/year. With DRIP reinvestment over 10 years, these grow to $2,355/year (MAIN) and $1,154/year (ABBV).
Does MAIN or ABBV pay monthly dividends?
MAIN pays monthly dividends. ABBV pays quarterly dividends. MAIN pays monthly, which is preferred by investors who need regular cash flow.
📬

Get this MAIN vs ABBV comparison by email

Save your analysis + get weekly dividend insights. Free forever.

More comparisons

MAIN vs ARCCMAIN vs HTGCMAIN vs GBDCMAIN vs ORCCMAIN vs CSWCMAIN vs JNJMAIN vs MRKMAIN vs PFEABBV vs JNJABBV vs MRKABBV vs PFEABBV vs BMY

⚠️ Educational purposes only. Not financial advice. All projections use historical data; actual results will vary.